Plasma NF-L was reported to increase in patients with MCI and AD compared with healthy controls and distinguish patients with AD from control with high accuracy (AUC = 0.87), a value comparable to plasma Aβ42/Aβ40 ratio results (Mattsson et al., 2017). This evidence concerns the gene NEFL and Alzheimer disease.